Effects of L-dopa on expression of prolactin and synaptotagmin IV in 17-beta-estradiol-induced prolactinomas of ovariectomized hemiparkinsonian rats

Effects of L-dopa on expression of prolactin and synaptotagmin IV in 17-beta-estradiol-induced prolactinomas of ovariectomized hemiparkinsonian rats
Bosn J Basic Med Sci. 2021 Mar 28. doi: 10.17305/bjbms.2021.5491. Online ahead of print.ABSTRACTParkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. Dopamine precursor L-dopa is used as the first-line treatment for PD. Evidence suggests neuroprotective effects of estrogens in PD. Since both estradiol (E2) and L-dopa act as regulators ... read more
Source: PubMedPublished on 2021-04-06By Maja Zorovic